Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Prostate Cancer

Free Subscription Articles published in Acta Radiol Retrieve available abstracts of 6 articles: HTML format

Single Articles

June 2025
1. CHENG H, Yang B, Cui Y, Liu M, et al
   SyMRI histogram analysis for diagnosing clinically significant prostate cancer.
   Acta Radiol. 2025 Jun 18:2841851251349488. doi: 10.1177/02841851251349488.
   PubMed     Abstract available
   
   
   April 2025
2. LIU X, Yang S, Deng W, Li D, et al
   The diagnostic performance and reader agreement of the Prostate Imaging for Recurrence Reporting system in the evaluation of local recurrence in patients with biochemically recurrent prostate cancer.
   Acta Radiol. 2025 Apr 23:2841851251334364. doi: 10.1177/02841851251334364.
   PubMed     Abstract available
   
   
   February 2025
3. SIROLU S, Seker ME, Alis D, Guroz B, et al
   Assessing the aggressiveness of prostate cancer using ADC and relaxation maps from synthetic MRI.
   Acta Radiol. 2025 Feb 18:2841851251315717. doi: 10.1177/02841851251315717.
   PubMed     Abstract available
   
   
   
4. LI Y, Zhou X, Zhang X, Zhang M, et al
   Bi-parametric MRI radiomic model for prostate cancer diagnosis: value of intralesional and perilesional radiomics.
   Acta Radiol. 2025 Feb 18:2841851251317646. doi: 10.1177/02841851251317646.
   PubMed     Abstract available
   
   
   January 2025
5. WEN X, Jiang CY, Jiang X, Chen Y, et al
   Comparative diagnostic performance of (68)Ga-PSMA-11 PET/CT and (68)Ga-PSMA-11 PET/MRI in detecting biochemical recurrent bone metastasis in prostate cancer: a systematic review and meta-analysis.
   Acta Radiol. 2025 Jan 26:2841851241307336. doi: 10.1177/02841851241307336.
   PubMed     Abstract available
   
   
   December 2023
6. KRAUSS W, Frey J, Heydorn Lagerlof J, Liden M, et al
   Radiomics from multisite MRI and clinical data to predict clinically significant prostate cancer.
   Acta Radiol. 2023 Dec 20:2841851231216555. doi: 10.1177/02841851231216555.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.